Journal rankings · indicator year 2009
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2009
Oncology journal rankings 2009
134 ranked journals · Subfield in Medicine
Oncology has 134 ranked journals in 2009. The median journal has an OJR of 0.93, below the world average of 1.00, down 0.01 on 2008; Q1 starts at OJR 1.47. The top three are CA A Cancer Journal for Clinicians, Cancer Cell, and Nature Medicine.
Ranks and citation indicators: 2009. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2006–2008, the window the 2009 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery500
- Pulmonary and Respiratory Medicine212
- Cardiology and Cardiovascular Medicine184
- Public Health, Environmental and Occupational Health180
- Oncology134
- Epidemiology119
- Infectious Diseases110
- Psychiatry and Mental health100
- Radiology, Nuclear Medicine and Imaging99
- Endocrinology, Diabetes and Metabolism95
- Physiology91
- Neurology87
Show all 42 subfields
- Pediatrics, Perinatology and Child Health64
- Orthopedics and Sports Medicine63
- Ophthalmology59
- Hematology55
- Dermatology51
- Obstetrics and Gynecology44
- Rheumatology39
- Nephrology37
- Pharmacology34
- Complementary and alternative medicine31
- Reproductive Medicine31
- Emergency Medicine30
- Geriatrics and Gerontology25
- Otorhinolaryngology21
- Pathology and Forensic Medicine18
- Rehabilitation18
- Immunology and Allergy16
- Critical Care and Intensive Care Medicine14
- Genetics11
- Hepatology10
- Anesthesiology and Pain Medicine9
- Urology9
- Gastroenterology7
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
134 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2008. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2006–2008, the window the 2009 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2006–2008 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2009. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 41.69Q1 | 102.64 20.78 up from 2008 | 62 | 100% | $4,330 | ||
2Cancer CellCell Press · Netherlands | 7.03Q1 | 18.26 0.47 down from 2008 | 371 | 100% | $10,400 | ||
3Nature MedicineNature Portfolio · United States | 5.46Q1 | 12.67 0.46 up from 2008 | 1,142 | 36% | $12,690 | ||
4Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 5.19Q1 | 11.97 0.20 down from 2008 | 3,196 | 14% | — | ||
5JNCI Journal of the National Cancer InstituteOxford University Press · United States | 4.77Q1 | 11.24 0.30 down from 2008 | 700 | 44% | $5,436 | ||
6The Lancet OncologyElsevier BV · United Kingdom | 4.17Q1 | 9.91 1.61 up from 2008 | 571 | 12% | $7,280 | ||
7Clinical Pharmacology & TherapeuticsWiley · United States | 3.13Q1 | 5.42 0.34 down from 2008 | 804 | 22% | $4,410 | ||
8The OncologistOAAlphaMed Press · United Kingdom | 3.11Q1 | 7.77 0.04 down from 2008 | 462 | 70% | $3,852 | ||
9Seminars in Cancer BiologyElsevier BV · United States | 2.87Q1 | 6.79 0.81 down from 2008 | 168 | 35% | $6,060 | ||
10Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 2.69Q1 | 7.16 0.44 up from 2008 | 3,357 | 60% | — | ||
11CancerWiley · United States | 2.69Q1 | 6.14 0.40 up from 2008 | 2,358 | 67% | $4,790 | ||
12Annals of OncologyElsevier BV · Netherlands | 2.28Q1 | 6.06 1.21 up from 2008 | 1,363 | 96% | $5,080 | ||
13Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 2.24Q1 | 5.34 0.02 down from 2008 | 321 | 3% | $4,190 | ||
14Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 2.19Q1 | 5.73 0.11 up from 2008 | 1,131 | 19% | — | ||
15British Journal of CancerSpringer Nature · United Kingdom | 2.02Q1 | 4.93 0.54 down from 2008 | 1,769 | 100% | $5,190 | ||
16Cancer Epidemiology Biomarkers & PreventionAmerican Association for Cancer Research · United States | 1.96Q1 | 4.71 0.31 down from 2008 | 1,416 | 68% | — | ||
17European Journal of CancerElsevier BV · United Kingdom | 1.95Q1 | 4.76 0.55 down from 2008 | 1,102 | 13% | $4,270 | ||
18Cancer Prevention ResearchAmerican Association for Cancer Research · United States | 1.95Q1 | 4.27 4.14 up from 2008 | 95 | 63% | — | ||
19Current Opinion in OncologyLippincott Williams & Wilkins · United Kingdom | 1.94Q1 | 4.61 0.16 up from 2008 | 275 | 11% | — | ||
20International Journal of CancerWiley · United States | 1.92Q1 | 4.75 0.13 down from 2008 | 2,415 | 69% | $5,030 | ||
21Journal of Mammary Gland Biology and NeoplasiaSpringer Science+Business Media · United States | 1.81Q1 | 4.43 0.13 down from 2008 | 97 | 44% | $4,090 | ||
22Cancer ControlOASAGE Publishing · United States | 1.81Q1 | 4.20 0.06 down from 2008 | 122 | 47% | $2,650 | ||
23Seminars in OncologyElsevier BV · United States | 1.81Q1 | 3.95 1.16 down from 2008 | 302 | 9% | $3,550 | ||
24Clinical & Experimental MetastasisSpringer Science+Business Media · Netherlands | 1.74Q1 | 4.57 1.12 up from 2008 | 215 | 29% | $5,090 | ||
25Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 1.72Q1 | 4.32 0.19 up from 2008 | 483 | 13% | — | ||
26Diseases of the Colon & RectumLippincott Williams & Wilkins · United States | 1.63Q1 | 3.67 0.34 up from 2008 | 790 | 2% | — | ||
27The Cancer JournalLippincott Williams & Wilkins · United States | 1.60Q1 | 3.83 0.78 up from 2008 | 190 | 16% | — | ||
28European Journal of EpidemiologySpringer Science+Business Media · Italy | 1.59Q1 | 3.88 1.01 up from 2008 | 345 | 27% | $3,690 | ||
29Cancer Treatment ReviewsElsevier BV · United Kingdom | 1.57Q1 | 5.77 0.88 up from 2008 | 247 | 8% | $4,910 | ||
30JBIC Journal of Biological Inorganic ChemistrySpringer Science+Business Media · Germany | 1.54Q1 | 3.15 0.23 down from 2008 | 371 | 50% | $3,990 | ||
31Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 1.52Q1 | 3.46 0.20 up from 2008 | 161 | 65% | — | ||
32Cancer Causes & ControlSpringer Science+Business Media · Netherlands | 1.52Q1 | 3.32 0.79 down from 2008 | 476 | 50% | $3,890 | ||
33Integrative Cancer TherapiesOASAGE Publishing · United States | 1.49Q1 | 2.27 0.41 down from 2008 | 122 | 100% | $2,650 | ||
34BMC CancerOABioMed Central · United Kingdom | 1.47Q1 | 3.59 0.11 down from 2008 | 927 | 100% | $3,390 | ||
35JNCI MonographsOxford University Press · United Kingdom | 1.45Q2 | 2.82 0.40 up from 2008 | 49 | — | — | ||
36Psycho-OncologyWiley · United Kingdom | 1.44Q2 | 2.99 0.23 up from 2008 | 389 | 30% | $4,940 | ||
37Journal of Inorganic BiochemistryElsevier BV · United States | 1.42Q2 | 3.19 0.01 up from 2008 | 734 | 12% | $4,220 | ||
38Current Treatment Options in OncologySpringer Science+Business Media · United States | 1.40Q2 | 2.57 0.74 down from 2008 | 124 | 7% | $4,890 | ||
39Hematology/Oncology Clinics of North AmericaElsevier BV · United States | 1.36Q2 | 3.33 0.43 up from 2008 | 220 | 19% | $3,950 | ||
40Journal of ImmunotherapyLippincott Williams & Wilkins · United States | 1.32Q2 | 3.36 1.05 down from 2008 | 244 | 30% | — | ||
41Breast Cancer ResearchOABioMed Central · United Kingdom | 1.32Q2 | 3.31 0.61 down from 2008 | 719 | 100% | $4,190 | ||
42MicrocirculationWiley · United States | 1.32Q2 | 2.78 0.55 down from 2008 | 179 | 36% | $3,920 | ||
43Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 1.30Q2 | 3.04 0.43 up from 2008 | 834 | 5% | — | ||
44CytotherapyElsevier BV · United Kingdom | 1.28Q2 | 2.70 0.94 down from 2008 | 253 | 11% | $3,300 | ||
45Journal of Clinical PathologyBMJ · United Kingdom | 1.28Q2 | 2.82 0.24 up from 2008 | 923 | 13% | — | ||
46Journal of Surgical OncologyWiley · United States | 1.27Q2 | 2.64 0.20 up from 2008 | 759 | 16% | $4,570 | ||
47Supportive Care in CancerSpringer Science+Business Media · Germany | 1.23Q2 | 2.39 0.46 down from 2008 | 534 | 18% | $4,690 | ||
48Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.22Q2 | 3.73 0.15 up from 2008 | 515 | 100% | $4,590 | ||
49American Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 1.19Q2 | 2.70 0.42 up from 2008 | 346 | 7% | — | ||
50Current Problems in CancerElsevier BV · United States | 1.19Q2 | 2.94 0.70 up from 2008 | 52 | 2% | $3,740 |
Subfields of Medicine, with Oncology highlighted.
- Surgery500
- Pulmonary and Respiratory Medicine212
- Cardiology and Cardiovascular Medicine184
- Public Health, Environmental and Occupational Health180
- Oncology134
- Epidemiology119
- Infectious Diseases110
- Psychiatry and Mental health100
- Radiology, Nuclear Medicine and Imaging99
- Endocrinology, Diabetes and Metabolism95
- Physiology91
- Neurology87
- Pediatrics, Perinatology and Child Health64
- Orthopedics and Sports Medicine63
- Ophthalmology59
- Hematology55
- Dermatology51
- Obstetrics and Gynecology44
- Rheumatology39
- Nephrology37
- Pharmacology34
- Complementary and alternative medicine31
- Reproductive Medicine31
- Emergency Medicine30
- Geriatrics and Gerontology25
- Otorhinolaryngology21
- Pathology and Forensic Medicine18
- Rehabilitation18
- Immunology and Allergy16
- Critical Care and Intensive Care Medicine14
- Genetics11
- Hepatology10
- Anesthesiology and Pain Medicine9
- Urology9
- Gastroenterology7
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2009. Corpus-wide, 71.4% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
48 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2006–2008, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2009. Publication window: 2006–2008. How these summaries are calculated
- Ranked journals
- 134
- Window papers (baseline)
- 71,283 +25.1% from indicator year 2006
- Median OJR
- 0.93 +8.8% from indicator year 2006
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2006–2008 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.